Birches Health
-66%
est. 2Y upside i
At Birches Health, we’re beating the online gambling epidemic with virtual therapy for gambling addiction from specialized clinicians. Our care is covered by insurance and state funding to ensure access to treatment for problem gamblers. We work with patients throughout their gambling addiction journey to improve clinical outcomes and reduce healthcare costs.
Rank
#1060
Sector
Behavioral Health
Est. Liquidity
~5Y
Data Quality
Data: MediumBirches Health offers a moderate upside opportunity for a job seeker, driven by its specialized niche in the large and growing behavioral addiction market and strong insurance partnerships.
Last updated: March 10, 2026
Birches Health successfully scales its specialized treatment model, expanding beyond gambling to capture significant market share in gaming and social media addictions, including for teens. Strong clinical outcomes and strategic insurance partnerships drive rapid revenue growth, justifying a 4x valuation to over $230M by 2028, potentially leading to an acquisition by a large healthcare player.
Birches Health maintains its leadership in the niche gambling addiction treatment market, steadily growing its patient base and strengthening existing insurance partnerships. Revenue grows consistently, leading to an eventual acquisition or next funding round at a valuation of approximately $100M-$110M, representing a solid return for early employees.
Increased competition from larger general behavioral health incumbents expanding into specialized addiction treatment, coupled with unforeseen regulatory hurdles or slower-than-expected market adoption, significantly hinders growth. The company struggles to raise its next funding round, leading to a down round or distressed sale at $10M-$15M, wiping out most common stock value due to the existing $20M liquidation preferences.
Preference Stack Risk
severeFunding Intensity
35%Investors hold $20M in liquidation preferences ahead of common stock, representing 34.48% of the current $58M valuation. In an exit at or below $58M, common stock holders would see significantly reduced or no returns until the $20M preference is paid out.
Dilution Risk
highAs a Series A company with only 9 employees, Birches Health will likely require multiple additional funding rounds (Series B, C, etc.) before a liquidity event, leading to substantial future dilution for common stock holders.
Secondary Liquidity
noneThere is no indication of active secondary markets or tender offers for Birches Health's equity at this early stage.
Questions to Ask at the Interview
Strategic questions based on Birches Health's data — designed to show you've done your homework.
- 1
“Given the significant incumbent threat from larger general behavioral health providers like Teladoc (BetterHelp) and Spring Health, how does Birches Health plan to maintain and expand its specialized market position in gambling and other behavioral addictions?”
- 2
“With only 9 employees reported, how does Birches Health plan to scale its operations, expand its provider network, and deepen payer relationships to achieve significant revenue growth towards a potential $200M+ valuation?”
- 3
“Considering the $20M in funding on a $58M valuation, resulting in a severe preference stack, what is the company's strategy for future funding rounds and eventual liquidity to ensure meaningful returns for common stock holders?”
Community
Valuation Sentiment
Our model estimates -66% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.